ProCE Banner Activity

Rationales for Using Immunotherapy-Based Regimens in Advanced Endometrial Cancer


Download these slides to review the biologic rationales for using established and investigational immunotherapy-based regimens in the treatment of advanced endometrial cancer.

Released: October 23, 2023



Ritu Salani

Ritu Salani, MD, MBA

Professor and Division Director
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
University of California, Los Angeles
Los Angeles, California

Lauren Prescott

Lauren Prescott, MD, MPH

Assistant Professor, Obstetrics and Gynecology
Division of Gynecologic Oncology
Vanderbilt University Medical Center
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from GSK.